AIDS · 2009 · 28 citations · 23 references
MedicineEndocrinologyAndrologyBone MetabolismReproductive EndocrinologyAndrogen DeficiencyAndrogen TherapyBone EndocrinologyBone HealthBone Metabolism DisordersBone Quality AssessmentAndrogen Effects On Bone DensityAndrogen Therapy In WomenBone Mineral DensityBone Mineral Density DeclineEquilibrium DialysisFree Testosterone AssessmentLow Bone Mineral DensityTestosterone Therapy
OBJECTIVE: Androgen deficiency is common in HIV-infected women. We investigated the long-term effects of transdermal testosterone on body composition, bone mineral density, quality of life, and safety. DESIGN: Twenty-five HIV-infected women with free testosterone below the median (< or =3 pg/ml) of the female normal range were randomized to receive transdermal testosterone (300 microg twice weekly) or identical placebo over 18 months. RESULTS: Women demonstrated low androgen levels (1.3 +/- 0.1 pg/ml) with relatively low weight (22.8 +/- 0.6 kg/m) and low bone mineral density (-0.61 +/- 0.17 SD hip T score) at baseline. No statistically significant differences were seen between the groups at baseline. The discontinuation rate was 16% and did not differ between treatment groups (P = 0.24). Free testosterone by equilibrium dialysis increased over 18 months (7.9 +/- 1.8 vs. 0.3 +/- 0.4 pg/ml; P = 0.002, testosterone vs. placebo). Testosterone was well tolerated and did not affect lipids, liver, or safety indices. Lean mass (1.8 +/- 0.5 vs. 0.8 +/- 0.9 kg; P = 0.04) and BMI (1.6 +/- 0.4 vs. 0.8 +/- 0.6 kg/m; P = 0.03, testosterone vs. placebo) increased in response to testosterone, whereas fat mass remained unchanged. Testosterone increased bone mineral density at the hip (0.01 +/- 0.01 vs. -0.01 +/- 0.01 g/cm; P = 0.02) and trochanter (0.01 +/- 0.01 vs. -0.02 +/- 0.01 g/cm; P = 0.01, testosterone vs. placebo). Testosterone significantly improved depression indices (-6.8 +/- 2.2 vs. -1.9 +/- 3.1; P = 0.02) and problems affecting sexual function (-1.8 +/- 0.8 vs. 0.5 +/- 0.5; P = 0.01, testosterone vs. placebo). CONCLUSION: Long-term testosterone administration was well tolerated in HIV-infected women and resulted in significant improvements in body composition, bone mineral density, and quality of life indices. Further evaluation of the safety and efficacy of testosterone use among HIV-infected women is warranted.
23
An Inventory for Measuring Depression
Aaron T. Beck · Archives of General Psychiatry · 1961 · 38.2K citations
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Susan R. Davis, Michèle Moreau, Robin Kroll et al. · New England Journal of Medicine · 2008 · 469 citations · Full text